Literature DB >> 19509555

Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control.

Elizabeth A Tracey1, David M Roder, Jane Francis, Helen M Zorbas, Neville F Hacker, James F Bishop.   

Abstract

We analyzed New South Wales Central Cancer Registry data for 1980-2003, to determine time trends in case fatality from ovarian cancer, after adjusting for stage, histological, and sociodemographic factors, and to consider service-delivery and research implications. After adjusting for covariates, the relative risk (95% confidence limit) of ovarian-cancer death reduced to 0.51 (0.46, 0.57) for 1999-2003 compared with 1980-1983. Relative risks were higher for adenocarcinomas and other specified and unspecified cancers than serous carcinomas, but lower for endometrioid carcinomas, sex cord-stromal and germ cell tumors. The probability of diagnosis with localized as opposed to more advanced disease was lower in older patients, the lowest socioeconomic stratum, women born in non-English-speaking countries, and more recent diagnostic periods. Approximately 61% of ovarian cancers had distant metastases at diagnosis in 1999-2003. Poorer survivals apply to older patients. Research directed at finding an effective screening test for epithelial ovarian cancer remains a priority.

Entities:  

Mesh:

Year:  2009        PMID: 19509555     DOI: 10.1111/IGC.0b013e3181a3a436

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  3 in total

1.  Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancer.

Authors:  Vanessa L Beesley; David D Smith; Christina M Nagle; Michael Friedlander; Peter Grant; Anna DeFazio; Penelope M Webb
Journal:  Support Care Cancer       Date:  2018-06-12       Impact factor: 3.603

2.  Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer.

Authors:  Vicente Escudero-Vilaplana; Elsa Bernal; Gema Casado; Roberto Collado-Borrell; Raúl Diez-Fernández; Ana Beatriz Fernández Román; Carlos Folguera; Lucía González-Cortijo; Marta Herrero-Fernández; Gloria Marquina; Concepción Martínez Nieto; Miguel Angel Rodríguez; Ana Rosa Rubio; Patricia Sanmartin-Fenollera; Maria José Vazquez Castillo; Marta Comellas; Eva Maria Guerra
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

3.  Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.

Authors:  Zeinab Hamidou; Sylvain Causeret; Tienhan S Dabakuyo; Julie Gentil; Laurent Arnould; Patrick Roignot; Thierry Altwegg; Marie-Laure Poillot; Franck Bonnetain; Patrick Arveux
Journal:  BMC Cancer       Date:  2010-11-10       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.